252 related articles for article (PubMed ID: 33403460)
21. Focal Therapy for Prostate Cancer: Pending Questions.
Cathelineau X; Sanchez-Salas R
Curr Urol Rep; 2016 Dec; 17(12):86. PubMed ID: 27761805
[TBL] [Abstract][Full Text] [Related]
22. Focal High Intensity Focused Ultrasound of Unilateral Localized Prostate Cancer: A Prospective Multicentric Hemiablation Study of 111 Patients.
Rischmann P; Gelet A; Riche B; Villers A; Pasticier G; Bondil P; Jung JL; Bugel H; Petit J; Toledano H; Mallick S; Rouvière O; Rabilloud M; Tonoli-Catez H; Crouzet S
Eur Urol; 2017 Feb; 71(2):267-273. PubMed ID: 27720531
[TBL] [Abstract][Full Text] [Related]
23. MR-Guided Transurethral Ultrasound Ablation (TULSA)-An Emerging Minimally Invasive Treatment Option for Localised Prostate Cancer.
Fung KFK; Cazzato RL; Tricard T; Marini PDE; Bertucci G; Autrusseau PA; Koch G; Weiss J; Garnon J; Lang H; Gangi A
Cardiovasc Intervent Radiol; 2024 Jun; 47(6):689-701. PubMed ID: 38491163
[TBL] [Abstract][Full Text] [Related]
24. Development of a Nationally Representative Coordinated Registry Network for Prostate Ablation Technologies.
Golan R; Bernstein A; Sedrakyan A; Daskivich TJ; Du DT; Ehdaie B; Fisher B; Gorin MA; Grunberger I; Hunt B; Jiang HH; Kim HL; Marinac-Dabic D; Marks LS; McClure TD; Montgomery JS; Parekh DJ; Punnen S; Scionti S; Viviano CJ; Wei JT; Wenske S; Wysock JS; Rewcastle J; Carol M; Oczachowski M; Hu JC
J Urol; 2018 Jun; 199(6):1488-1493. PubMed ID: 29307684
[TBL] [Abstract][Full Text] [Related]
25. Feasibility of MRI-guided transurethral ultrasound for lesion-targeted ablation of prostate cancer.
Anttinen M; Mäkelä P; Suomi V; Kiviniemi A; Saunavaara J; Sainio T; Horte A; Eklund L; Taimen P; Sequeiros RB; Boström PJ
Scand J Urol; 2019 Oct; 53(5):295-302. PubMed ID: 31556779
[No Abstract] [Full Text] [Related]
26. Histotripsy: The Next Generation of High-Intensity Focused Ultrasound for Focal Prostate Cancer Therapy.
Dubinsky TJ; Khokhlova TD; Khokhlova V; Schade GR
J Ultrasound Med; 2020 Jun; 39(6):1057-1067. PubMed ID: 31830312
[TBL] [Abstract][Full Text] [Related]
27. Impact of Focal Versus Whole Gland Ablation for Prostate Cancer on Sexual Function and Urinary Continence.
Borges RC; Tourinho-Barbosa RR; Glina S; Macek P; Mombet A; Sanchez-Salas R; Cathelineau X
J Urol; 2021 Jan; 205(1):129-136. PubMed ID: 33119421
[TBL] [Abstract][Full Text] [Related]
28. Magnetic Resonance-Guided Thermal Therapy for Localized and Recurrent Prostate Cancer.
Woodrum DA; Kawashima A; Gorny KR; Mynderse LA
Magn Reson Imaging Clin N Am; 2015 Nov; 23(4):607-19. PubMed ID: 26499278
[TBL] [Abstract][Full Text] [Related]
29. Pathological Findings and Magnetic Resonance Imaging Concordance at Salvage Radical Prostatectomy for Local Recurrence following Partial Ablation Using High Intensity Focused Ultrasound.
Thompson JE; Sridhar AN; Tan WS; Freeman A; Haider A; Allen C; Moore CM; Orczyk C; Mazzon G; Khetrapal P; Shaw G; Rajan P; Mohammed A; Briggs TP; Nathan S; Kelly JD; Sooriakumaran P
J Urol; 2019 Jun; 201(6):1134-1143. PubMed ID: 30730409
[TBL] [Abstract][Full Text] [Related]
30. Utility of Ultrasound in the Diagnosis, Treatment, and Follow-up of Prostate Cancer: State of the Art.
Chen FK; de Castro Abreu AL; Palmer SL
J Nucl Med; 2016 Oct; 57(Suppl 3):13S-18S. PubMed ID: 27694164
[TBL] [Abstract][Full Text] [Related]
31. Salvage radical prostatectomy following primary high intensity focused ultrasound for treatment of prostate cancer.
Lawrentschuk N; Finelli A; Van der Kwast TH; Ryan P; Bolton DM; Fleshner NE; Trachtenberg J; Klotz L; Robinette M; Woo H
J Urol; 2011 Mar; 185(3):862-8. PubMed ID: 21239003
[TBL] [Abstract][Full Text] [Related]
32. Role of MRI in minimally invasive focal ablative therapy for prostate cancer.
Rosenkrantz AB; Scionti SM; Mendrinos S; Taneja SS
AJR Am J Roentgenol; 2011 Jul; 197(1):W90-6. PubMed ID: 21701001
[TBL] [Abstract][Full Text] [Related]
33. Utility of Magnetic Resonance Imaging for Localizing Prostate Cancer Near the Urethra in Men Who Are Candidates for Focal Gland Ablation.
Patel N; Hughes A; Zhang JH; Brisbane W; Rastegarpour A; Afsahir S; Kwan L; Nguyen AV; Sisk A; Raman S; Reiter R
J Urol; 2023 May; 209(5):911-917. PubMed ID: 36753630
[TBL] [Abstract][Full Text] [Related]
34. Focal Therapy for Localized Prostate Cancer with Either High Intensity Focused Ultrasound or Cryoablation: A Single Institution Experience.
Tourinho-Barbosa RR; Sanchez-Salas R; Claros OR; Collura-Merlier S; Bakavicius A; Carneiro A; Stabile A; Moschini M; Cathala N; Tobias-Machado M; Cathelineau X
J Urol; 2020 Feb; 203(2):320-330. PubMed ID: 31437121
[TBL] [Abstract][Full Text] [Related]
35. High Intensity Focused Ultrasound Hemigland Ablation for Prostate Cancer: Initial Outcomes of a United States Series.
Abreu AL; Peretsman S; Iwata A; Shakir A; Iwata T; Brooks J; Tafuri A; Ashrafi A; Park D; Cacciamani GE; Kaneko M; Duddalwar V; Aron M; Palmer S; Gill IS
J Urol; 2020 Oct; 204(4):741-747. PubMed ID: 32898975
[TBL] [Abstract][Full Text] [Related]
36. Spatial Tracking of Targeted Prostate Biopsy Locations: Moving Towards Effective Focal Partial Prostate Gland Ablation with Improved Treatment Planning.
Sidelsky S; Setia S; Vourganti S
Curr Urol Rep; 2017 Oct; 18(12):93. PubMed ID: 29046984
[TBL] [Abstract][Full Text] [Related]
37. Novel Automated Three-Dimensional Surgical Planning Tool and Magnetic Resonance Imaging/Ultrasound Fusion Technology to Perform Nanoparticle Ablation and Cryoablation of the Prostate for Focal Therapy.
Jue JS; Coons S; Hautvast G; Thompson SF; Geraats J; Richstone L; Schwartz MJ; Rastinehad AR
J Endourol; 2022 Mar; 36(3):369-372. PubMed ID: 34409850
[No Abstract] [Full Text] [Related]
38. Magnetic resonance image guided transurethral ultrasound prostate ablation: a preclinical safety and feasibility study with 28-day followup.
Burtnyk M; Hill T; Cadieux-Pitre H; Welch I
J Urol; 2015 May; 193(5):1669-75. PubMed ID: 25464003
[TBL] [Abstract][Full Text] [Related]
39. Novel focal therapy treatment options for prostate cancer.
Werntz RP; Eggener SE
Curr Opin Urol; 2018 Mar; 28(2):178-183. PubMed ID: 29232270
[TBL] [Abstract][Full Text] [Related]
40. MR-Guided Transurethral Ultrasound Ablation (TULSA): An Emerging Minimally Invasive Treatment Option for Localised Prostate Cancer.
Akhlaghpour S
Cardiovasc Intervent Radiol; 2024 Jun; 47(6):702-704. PubMed ID: 38710796
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
